Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 601 - 650 out of 9,513

Document Document Title
WO/2007/013974A2
The present invention provides synthetic processes for the preparation of sulfonyl halides of Formula Ar- (R) 2-SO2-X and sulfonamides of Formula Ar-(R)2-SO2- NR4R5, where the constituent variables are as defined herein, that are useful ...  
WO/2007/010356A2
The invention relates to a process for the preparation of compounds of formula (I) wherein Q1 is a group selected from formulae (II) & (III) and a group *-NR6 -Q2-A or, if appropriate, their pharmaceutically acceptable salts and/or isome...  
WO/2007/010356A3
The invention relates to a process for the preparation of compounds of formula (I) wherein Q1 is a group selected from formulae (II) & (III) and a group *-NR6 -Q2-A or, if appropriate, their pharmaceutically acceptable salts and/or isome...  
WO/2007/009798A2
A process of producing a compound of formula (3), wherein R1 is a C1-5alkyl group, R2 is a halogen atom, a C1-5 alkyl group, a C2-5 alkenyl group, a C2-5 alkynyl group, a C1-5 alkyl group, a C1-5 alkoxy group, a nitro group, or a hydroxy...  
WO/2007/009798A3
A process of producing a compound of formula (3), wherein R1 is a C1-5alkyl group, R2 is a halogen atom, a C1-5 alkyl group, a C2-5 alkenyl group, a C2-5 alkynyl group, a C1-5 alkyl group, a C1-5 alkoxy group, a nitro group, or a hydroxy...  
WO/2007/006387A2
The invention relates to a method for producing onium-alkylsulfonates by reacting an onium halogenide or carboxylate with a symmetrically substituted dialkyl sulphite or with a asymmetrically substituted dialkyl sulphite at temperatures ...  
WO/2007/006387A3
The invention relates to a method for producing onium-alkylsulfonates by reacting an onium halogenide or carboxylate with a symmetrically substituted dialkyl sulphite or with a asymmetrically substituted dialkyl sulphite at temperatures ...  
WO/2007/006300A1
The invention relates to producing monomer, oligomer and polymer non-fluorinated, partially fluorinated or perfluorinated sulphonic acids by reacting halogenated, low-molecular weight, oligomer or macromolecular arenes with (hydrogen) su...  
WO/2007/004077A2
The invention includes an improved process for producing tamsulosin comprising reacting 5-(2-aminopropyl)-2-methoxybenzenesulfonamide with 2-(o-ethoxyphenoxy)ethyl bromide in an organic phosphite solvent to obtain tamsulosin. Optically p...  
WO/2007/004077A3
The invention includes an improved process for producing tamsulosin comprising reacting 5-(2-aminopropyl)-2-methoxybenzenesulfonamide with 2-(o-ethoxyphenoxy)ethyl bromide in an organic phosphite solvent to obtain tamsulosin. Optically p...  
WO/2007/005430A1
The present application provides a process to produce fluorinated vinyl ether by reacting a 2-alkoxypropionyl fluoride with a metal carbonate under anhydrous conditions in a stirred bed reactor at a temperature above the decarboxylation ...  
WO/2006/137473A1
A process for producing an aromatic sulfonic acid compound, comprising sulfonating a compound having at least one aromatic ring with the use of any of compounds of the formula (1) as a sulfonating agent. This provides a process for produ...  
WO/2006/136919A1
The present invention relates to a method for the preparation of Florfenicol from Fluoroamine compound, namely (1R,2S)-1-[4-(methylsulfonyl)phenyl]-2-amino-3-fluoro-1-prop anol (II), by reaction with dihaloacetic acid ester in an organic...  
WO/2006/137774A1
There is provided a process for the preparation of a compound of formula I, which process comprises: (a) reaction of a compound of formula II, HO-D-NH2 II with a compound of formula III, followed by (b) reaction of the intermediate of fo...  
WO/2006/134212A3
The invention relates to a process for the production of tamsulosin hydrochloride crystals where the crystal size distribution is controlled by controlling the temperature where hydrochloric acid is added to the reaction mixture.  
WO/2006/134212A2
The invention relates to a process for the production of tamsulosin hydrochloride crystals where the crystal size distribution is controlled by controlling the temperature where hydrochloric acid is added to the reaction mixture.  
WO/2006/131757A1
The present invention relates to a process for preparing certain sulphonamide intermediates useful in the preparation of HIV inhibitors and to the crystal forms thereof.  
WO/2006/133330A1
Hydrofluoroalkanesulfonates of the general formula R-O-CXH-CX2-SO3M, where R is selected from the group consisting of alkyl groups, functionalized alkyl groups, and alkenyl groups; X is selected from the group consisting of hydrogen and ...  
WO/2006/133331A1
A process for manufacture of hydrofluoroalkanesulfonic acid with at least one hydrogen bonded to the carbon atom adjacent to the carbon atom bonded to the sulfonic acid group comprising: contacting a fluoroolefin with sulfite in an aqueo...  
WO2006006156A3
The invention provides methods for detection of medical disorders, associated with cellular oxidative stress, cell degeneration and / or cell death. The invention further relates to compounds comprising a thiol (-SH) group, for detecting...  
WO2006019358A3
The present invention relates to a process for preparing Tamsulosin, an anti-benign prostatic hyperplasia drug, which comprises converting o-ethoxyphenoxyethanol to a corresponding sulfonate, and reacting the sulfonate with (R)-(-)-5-(2-...  
WO/2006/127184A1
The present invention is directed to a process for the preparation of sulphonylimine derivatives [particularly those of formula (XII)] and sulphamide derivatives [particularly those of formula (I)]. The process comprises reacting an alde...  
WO/2006/120816A1
A process in which a functional molecule capable of ionic dissociation which is stable not only chemically but also thermally under operating conditions required for electrochemical apparatus, such as fuel cells, being suitable for use a...  
WO/2006/117662A3
The invention relates to processes for the preparation of polymorphic forms of (R)-(-)- tamsulosin. More particularly, it relates to the preparation of polymorphic forms of (R)-(-)- tamsulosin designated as Form I and II. The invention a...  
WO/2006/117662A2
The invention relates to processes for the preparation of polymorphic forms of (R)-(-)- tamsulosin. More particularly, it relates to the preparation of polymorphic forms of (R)-(-)- tamsulosin designated as Form I and II. The invention a...  
WO/2006/113910A3
The present invention relates to compounds which are inhibitors of microsomal triglyceride transfer protein and/or apolipoprotein B (Apo B) secretion. These compounds can be useful for the prevention and treatment of various diseases, pa...  
WO/2006/109570A1
Disclosed is a method for commercially advantageously producing 2-isopropenyl-5-methyl-4-hexen-1-yl 3-methyl-2-butenoate with high yield. Specifically disclosed is a method for producing 2-isopropenyl-5-methyl-4-hexen-1-yl 3-methyl-2-but...  
WO/2006/108883A1
The present invention relates to a method for preparing a highly soluble linear alkyl benzene sulphonate (LAS). Specifically, the method includes adding a hydrotropic composition before or after the sulphonation of the linear alkyl benze...  
WO/2006/106800A1
Disclosed is a method for producing a compound (III), a salt thereof or a solvate of them by reacting a compound (I), a salt thereof or a solvate of them with a compound (II) in a toluene solvent in the presence of an additive such as wa...  
WO/2006/106960A1
A disulfonyl fluoride compound is easily and efficiently produced through a coupling reaction. The compound is converted to produce a useful compound. A compound (1) in which Y is fluorine is subjected to a photocoupling reaction, while ...  
WO/2006/106244A3
The invention relates to a method for preparing a compound of formula (I) in which: R1, R2, R3, while being identical or different, are protective groups and Nu is a nucleophilic group, to a method in which a nucleophilic compound is rea...  
WO/2006/106244A2
The invention relates to a method for preparing a compound of formula (I) in which: R1, R2, R3, while being identical or different, are protective groups and Nu is a nucleophilic group, to a method in which a nucleophilic compound is rea...  
WO2005069751A3
Radicals with unpaired electrons are used to initiate a chain reaction that converts small hydrocarbons such as methane into oxygenated liquids. An initiator such as Marshall's acid is used to create methyl radicals. These radicals combi...  
WO/2006/097421A1
The present invention relates to a method of removing SO2 contaminants from dimethyl sulfate (DMS) by treatment with an oxidizing agent, and to a process for the preparation of odour free fatty acid trialkanolamine esters quaternized wit...  
WO/2006/091870A3
α,β-Unsaturated sulfides, sulfones, sulfoxides and sulfonamides according to Formula (I): wherein Ar1, Ar2, X, n, * and R are as defined herein, are prepared by dehydration of β-hydroxy sulfides, sulfones, sulfoxides or sulfonamides.  
WO2006052522A3
Disclosed are methods for making the phosphonium sulfonate salt of generic formula: (1): wherein each X is independently a halogen or hydrogen, provided that the molar ratio of halogen to hydrogen is greater than about 0.90; p is 0 or 1 ...  
WO/2006/087166A1
Provided is a process for the preparation of N-monosubstituted β-aminoalcohol sulfonates of formula (Ia), (Ib) wherein R1 is C6-20 aryl or C4-12 heteroaryl, each optionally being substituted with one or more halogen atoms and/or one or ...  
WO/2006/072259A3
The quantitatively most important pathway for the excretion of cholesterol in mammals is the formation of bile salts (the conjugate bases of bile acids). The major bile salts are synthesized and secreted by as glycine or taurine conjugat...  
WO/2006/072259A2
The quantitatively most important pathway for the excretion of cholesterol in mammals is the formation of bile salts (the conjugate bases of bile acids). The major bile salts are synthesized and secreted by as glycine or taurine conjugat...  
WO2005044795A8
The present invention provides an efficient synthesis for the preparation of ((1R,3S)-3-isopropyl-3- {[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl] carbonyl} cyclopentyl)[(3S,4S)-3-m ethoxytetrahydro- 2H-pyran-4-yl]amine an...  
WO/2006/061549A1
A process for producing tamsulosin of formula (I) and pharmaceutically acceptable addition salts, thereof comprises the steps of : a) Reacting compound R,R-[2-(4-methoxy-phenyl)-1-methyl-ethyl]-(1-phenyl-ethyl)-a mine of formula (II) or ...  
WO/2006/059700A1
Disclosed is a separating agent for asymmetric substances which has high separation performance. Specifically disclosed is a polysulfonamide derivative represented by the following formula (1) or (2). (In the formulae, R represents an op...  
WO/2006/051697A1
Disclosed is a method for producing a fluorine-containing fluorosulfonyl alkylvinyl ether represented by the following chemical formula: CF2=CFOCF2CF2SO2F which is characterized in that a fluorine-containing chlorosulfonyl alkylvinyl eth...  
WO/2006/052522A2
Disclosed are methods for making the phosphonium sulfonate salt of generic formula: (1): wherein each X is independently a halogen or hydrogen, provided that the molar ratio of halogen to hydrogen is greater than about 0.90; p is 0 or 1 ...  
WO2005108441A3
A polymer is provided in which a sulfonic group or a derivative thereof is introduced. The polymer includes a unit represented by the following chemical formula (1): wherein R represents -A1-SO2R1; A1 is selected from an alkylene group, ...  
WO2005123646A3
The production of fluoroorganic compounds in the form of amidoamines, quaternised compounds thereof, amides and ethers, guanidides, hydrazides, ureides, thioureides, perfluoropolyoxaalkylenesulfo- or perfluoropolyoxaalkylenecarboxylic ac...  
WO/2006/042678A1
The invention relates to a method for cleaning 3-hydroxyamidinophenylalanine derivatives comprising the steps: (a) addition of an aromatic sulphonic acid to a solution of an optionally contaminated 3-hydroxyamidinophenylalanine derivativ...  
WO/2006/040131A1
The invention relates to a method for combining carbon-carbon bonds starting from a copper compound of an aryl, heteroaryl, alkene or alkine and an aryl, heteroaryl, alkene or alkine compound with a suitable nucleofuge. The copper compou...  
WO2005081777A3
Severely sterically hindered secondary aminoether alcohols are prepared by reacting an organic carboxylic acid or alkali metal salt of an organic carboxylic acid with a sulfonyl halide, a sulfuryl halide, a mixed sulfuryl ester halide or...  
WO/2006/023611A1
The present invention provides method for making a compound of formula (1) comprising the steps of reacting compounds of formulas (2) and (3) to produce a compound of formula (4) wherein R1, R2, R3, R4 and R5 are defined as described her...  

Matches 601 - 650 out of 9,513